WeVote
Log In

Bill

Bill

HB 533

An Act amending the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, in preliminary provisions, further providing for definitions.

2025-2026 Regular Session Introduced by Joe Ciresi and 7 co-sponsors

Pennsylvania bill revises Medical Marijuana Act definitions to clarify program eligibility and regulatory scope, pending Health Committee review.

Referred to Health
0
WeVote Research Nonpartisan
Bill Summary · HB 533

Legislative bill overview

HB 533 proposes amendments to Pennsylvania's 2016 Medical Marijuana Act by revising definitions in the preliminary provisions. The bill has been referred to the Health Committee but the specific definitional changes are not detailed in the available legislative summary.

Why is this important

Definitional changes in medical marijuana legislation can significantly impact program eligibility, patient access, provider licensing requirements, and regulatory oversight. How terms like "medical marijuana," "qualifying conditions," or "medical use" are defined directly affects who can participate in the program and what products are permitted.

Potential points of contention

  • Scope of qualifying conditions – expanding or narrowing the medical conditions eligible for medical marijuana treatment affects patient access and program costs
  • Product definitions – clarifying what forms marijuana can take (flower, concentrates, edibles, etc.) influences regulatory burden and pharmaceutical concerns
  • Definitional clarity for providers – changes to how growers, processors, or dispensaries are defined could affect licensing standards, industry consolidation, or market competition

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.